Buse Bor: New Publication on Therapeutic Interventions for Women with Obstetric APS
Buse Bor, Board member and volunteer at Bamsehospitalet og Sundkrop of IMCC (International Medical Cooperation Committee), shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Seminars in Thrombosis and Hemostasis, adding:
“Excited to share that our scoping review on Therapeutic Interventions for Women with Obstetric Antiphospholipid Syndrome has now been published in Seminars in Thrombosis and Hemostasis.
This collaboration started back in 2023 after writing my bachelor thesis in this field together with Bent Deleuran and a research stay in London, since then I have found the topic both important and interesting. I truly believe it deserves more attention.
A big thank you to all my co-authors for their contributions and collaboration Bent Deleuran, Karen Schreiber, Vakur Bor.”
Title: Therapeutic Interventions for Obstetric Antiphospholipid Syndrome Associated with Recurrent Pregnancy Loss: A Scoping Review of Randomized Controlled Trials on Live Birth Outcomes
Authors: Buse Bor, Karen Schreiber, Bent Winding Deleuran, Mustafa Vakur Bor

Stay updated on all scientific advances with Hemostasis Today.
-
Aug 23, 2026, 17:51Gurpreet Kaurr: A Proud Milestone in Haematology and Oncology
-
Aug 23, 2026, 17:33Kathrine Kaspersen: How Voluntary Plasma Donors Helped Transform Denmark’s Plasma Supply
-
Aug 23, 2026, 16:51Sthanu Subramanian: Empagliflozin and a Rise in Hematocrit
-
Aug 23, 2026, 16:50Lale Tokgözoğlu: New PCSK9i Research Published in the European Heart Journal
-
Aug 23, 2026, 16:44Eric Gehrie: Your 2026 Guide to the Essentials of Transfusion Medicine
-
Aug 23, 2026, 16:35Thomas Dayspring: The Overlooked Pathway in Cholesterol Homeostasis
-
Aug 23, 2026, 16:28Evan Mapelu: The People Who Make Cancer Care Meaningful
-
Aug 23, 2026, 16:09Felice Gragnano: New Publication on Aspirin Discontinuation After PCI for Acute Coronary Syndromes
-
Aug 23, 2026, 16:06Mostafa Faisal: Donor Type and Long-Term Quality of Life After HCT for Severe Aplastic Anemia